Live from ESMO 2024 | Ascentage Pharma Releases Latest Data Showing Sustained Clinical Efficacy of Olverembatinib in SDH-Deficient GIST during a Mini Oral Presentation September 14, 2024 — 08:18
4 Days of Family Fun at Cotai Expo – Free-Admission Sands Shopping Carnival Open Now July 19, 2024 — 13:45
Gan & Lee Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the American Diabetes Association’s 84th Scientific Sessions June 23, 2024 — 21:09
Cubic Invests in LOPE and Jingding Electric to Create a Comprehensive Supply Chain for Premixed Gas Condensing Boilers June 13, 2024 — 01:01
Consumer ByteDance Prepares Subsidiary Dongchedi for IPO With a Valuation of $3 Billion, Potentially the First Public Listing for TikTok Parent June 12, 2024 — 23:48
Nuren Group Announces Upcoming IPO on National Stock Exchange of Australia (NSX): Empowering Women Through Innovation June 12, 2024 — 14:09
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024 June 11, 2024 — 08:10
Trip.com Group Limited Announces Completion of Offering of US$1.5 Billion Cash-par Settled Convertible Senior Notes June 8, 2024 — 04:05
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016 May 22, 2024 — 09:16
Blockchain Hong Kong’s Bitcoin and Ethereum Spot ETFs Suffer Disappointing Debut, Yet Hope for Future Growth Persists April 30, 2024 — 23:36
Introducing Wacom Movink: The first OLED pen display, and the thinnest and lightest Wacom pen display ever April 24, 2024 — 13:00
Bridgewise secures $21 million in new funding to support the global expansion of its AI-powered financial intelligence platform for global securities April 16, 2024 — 12:01
AI SenseTime Grapples with Losses a Decade After Its Inception, Pinning Hopes on Generative AI to Drive Profitability April 3, 2024 — 00:56
Mezzion Pharmaceuticals Announces Dr. Rahul Rathod of Boston Children’s Hospital and Harvard Medical School as the Global Principal Investigator for the Confirmatory Pivotal Phase 3 Trial FUEL-2 March 2, 2024 — 10:26
Fosun International Included in S&P Global’s Sustainability Yearbook 2024 and Recognized as Industry Mover February 9, 2024 — 09:00
AI Second Co-Founder Exits China’s Nvidia Challenger Biren Tech, Casting Uncertainty on Potential Hong Kong IPO January 26, 2024 — 01:35
Zhihu Announces Receipt of NYSE Notification Regarding ADS Trading Price Requirement December 30, 2023 — 05:05
AI SenseTime Overcomes Founder’s Sudden Passing, Poised for Growth in Generative AI Sector December 30, 2023 — 01:10
Consumer TikTok’s Strategic Compromise: Navigating Local Protectionism with $1.5 Billion Tokopedia Deal for Indonesian Market Re-entry December 21, 2023 — 00:25
